Analytical Trends in Biotherapeutics Development and Quality Control

  • Overview
  • Venue
Date(s): 31 October 2017
Time: 8:30am - 4:00pm
Location: St. Louis, MO
Language: English

A MilliporeSigma and Waters Free Technology Event.


8:30am  Arrival/Registration/Continental Breakfast
9:00am  Welcome
Aaron Sin, MilliporeSigma
9:15am  Event Introduction and Historical Perspectives on Collaborative Programs
Bob Burgoyne, Waters Corporation 
9:30am  Native Ion Mobility-Mass Spectrometry: Applications in Characterizing Biotherapeutic Structural Dynamics and Stability
Richard Kerr, US FDA 
10:00am  Analysis of Antibody Drug Conjugate (ADC) by Denaturing Capillary Electrophoresis (CE-SDS) and Imaging Capillary Isoelectric Focusing (icIEF)
Rowel Tobias, EAG Laboratories 
10:30am   Networking Poster Session/Break
11:00am  Novel Tools and Techniques for the Characterization and Quantification of Therapeutic Proteins by Mass Spectrometry
Jeff Turner, MilliporeSigma
11:30am  Deploying a Fit for Purpose LCMS Platform in Biopharmaceutical Regulated Development and QC
Min Du, Waters Corporation
12:00pm  Complimentary Lunch
1:00pm  Amino Acid Analysis (AAA) of Cell Media Using Waters AccQ-Tag Chemistry
Qing Chang, Pfizer
1:30pm Breakout Session # 1: Application of MS Technology- from Biologics Development into GMP Environment
Session Leaders: Justin Sperry and Min Du
2:00pm Break w/Refreshments
2:15pm Breakout Session # 2: Regulation, Challenges and Analytical Methods for Host Cell Proteins
Session Leaders: Thomas Powers and Gordon Nicol
2:45pm Breakout Session # 3: Current State and Characterization Assays for Antibody-Drug Conjugates
Session Leaders: Andrew Dawdy and Lisa McDermott
3:15pm Summary of the Breakout Sessions
3:45pm Closing
Gene Coppi, Waters Corporation

For additional information or questions, please contact